Drugs / K-285
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03712241 | Oct 2018 → Jan 2019 | — | Kowa Research Institute, Inc. | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT04484428 | Aug 2020 → Mar 2021 | — | Kowa Research Institute, Inc. | Terminated | Missed primary Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K-285 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04484428 ↗ |
| Route | Topical | “Topical” NCT03712241 ↗ |